Nutriband Inc Total Assets
Nutriband Inc total assets. Based on the latest financial reports, Nutriband Inc (NTRB) holds total assets worth $6.29 Million USD as of July 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see market cap of Nutriband Inc for the company's overall valuation and market capitalisation.
Total Assets of Nutriband Inc (2016–2026)
Total assets of Nutriband Inc from 2016 to 2026. This chart illustrates how Nutriband Inc's total assets have evolved over time, based on quarterly financial data. See NTRB share price today for real-time trading data and today's change.
Nutriband Inc - Asset Composition Analysis
Nutriband Inc Total Assets Breakdown (January 2026)
Nutriband Inc total assets breakdown as of January 2026. Nutriband Inc's total assets of $6.29 Million consist of 66.1% current assets and 33.9% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 60.6% |
| Accounts Receivable | $118.40K | 1.6% |
| Inventory | $117.99K | 1.6% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $200.43K | 2.7% |
| Goodwill | $1.72 Million | 22.8% |
Asset Composition Trend (2016–2026)
This chart illustrates how Nutriband Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore how liquid is Nutriband Inc's working capital to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Nutriband Inc's current assets represent 66.1% of total assets in 2026, a decrease from 100.0% in 2016.
- Cash Position: Cash and equivalents constituted 60.6% of total assets in 2026, up from 30.3% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 24.0% of total assets, an increase from 0.0% in 2016.
- Asset Diversification: The largest asset category is goodwill at 22.8% of total assets.
Nutriband Inc Competitors by Total Assets
Key competitors of Nutriband Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Hyloris Developmentsen Sa
BR:HYL
|
Belgium | €37.05 Million |
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
|
USA | $11.72 Billion |
|
Oruka Therapeutics, Inc.
NASDAQ:ORKA
|
USA | $1.14 Billion |
|
Gempharmatech Co. Ltd. A
SHG:688046
|
China | CN¥2.80 Billion |
|
Vor Biopharma Inc
NASDAQ:VOR
|
USA | $481.05 Million |
|
Inventiva S.A
PA:IVA
|
France | €249.51 Million |
|
Sunmax Biotechnology Co Ltd
TWO:4728
|
Taiwan | NT$1.90 Billion |
|
Apnimed, Inc. Common Stock
NASDAQ:APMD
|
USA | $342.63 Million |
Nutriband Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.21 | 4.78 | 5.92 |
| Quick Ratio | 4.02 | 4.70 | 5.80 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $2.91 Million | $5.95 Million | $4.94 Million |
Nutriband Inc - Advanced Valuation Insights
This section examines the relationship between Nutriband Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 13.84 |
| Latest Market Cap to Assets Ratio | 9.34 |
| Asset Growth Rate (YoY) | 1.0% |
| Total Assets | $7.55 Million |
| Market Capitalization | $70.50 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Nutriband Inc's assets at a significant premium (9.34x), suggesting investors see substantial growth potential or unique competitive advantages.
Positive Asset Growth: Nutriband Inc's assets grew by 1.0% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Nutriband Inc (2016–2026)
The table below shows the annual total assets of Nutriband Inc from 2016 to 2026.
| Year | Total Assets | Change |
|---|---|---|
| 2026-01-31 | $7.55 Million | +1.04% |
| 2025-01-31 | $7.47 Million | -0.63% |
| 2024-01-31 | $7.52 Million | -20.51% |
| 2023-01-31 | $9.46 Million | -25.77% |
| 2022-01-31 | $12.74 Million | +28.33% |
| 2021-01-31 | $9.93 Million | +351.71% |
| 2020-01-31 | $2.20 Million | -21.72% |
| 2019-01-31 | $2.81 Million | +1602.63% |
| 2018-01-31 | $164.90K | +337.08% |
| 2017-01-31 | $37.73K | +11332.42% |
| 2016-01-31 | $330.00 | -- |
About Nutriband Inc
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products in the United States. Its lead product is AVERSA Fentanyl, an abuse deterrent fentanyl patch for the treatment of chronic pain. The company also develops AVERSA buprenorphine and AVERSA methylphenidate. It has a commercial development and clinical supply agreement for Aversa Fentanyl with Kindeva Drug Delivery. The company… Read more